Peter Caldini

Peter Caldini

Chief Executive Officer at ESTABLISHMENT LABS HOLDINGS INC.

Net worth: 2 M $ as of 31/05/2026

61 year
Health Technology
Consumer Services
Process Industries

Profile

Peter Caldini is President, Chief Executive Officer & Director at Establishment Labs Holdings, Inc. starting in 2025.
Mr. Caldini is Director at Solvotrin Therapeutics Ltd. and Director at Premark Pharma GmbH.
Former roles include Chief Executive Officer & Director at Acreage Holdings, Inc. from 2020 to 2023, Director at Arcadia Consumer Healthcare, Inc., Director at Bespoke Capital Acquisition Corp.
in 2020, General Manager-Bayer Consumer Care China at Bayer Plc from 2009 to 2014, and Regional President-North America at Pfizer Consumer Healthcare (United Kingdom) from 2017 to 2019.
Education includes undergraduate studies at Boston University, an MBA from Northeastern University, and graduate studies at SDA Bocconi School of Management.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
31/03/2026 27,464 ( 0.09% ) 2 M $ 31/05/2026

Peter Caldini active positions

CompaniesPositionStart
ESTABLISHMENT LABS HOLDINGS INC. Chief Executive Officer 01/03/2025
Director/Board Member -
Director/Board Member -

Former positions of Peter Caldini

CompaniesPositionEnd
ACREAGE HOLDINGS, INC. Chief Executive Officer 30/06/2023
BESPOKE CAPITAL ACQUISITION CORP. Chief Executive Officer 31/12/2020
Corporate Officer/Principal 01/01/2019
Corporate Officer/Principal 01/01/2014
Director/Board Member -
See the detail of Peter Caldini's experience

Training of Peter Caldini

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

8

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Process Industries

Consumer Services

Commercial Services

Consumer Services

Retail Trade

Consumer Services

Health Technology

Health Technology

Finance

Health Technology

Health Technology